公司资料
Vigil Neuroscience 股价、新闻与催化剂
- 股票代码:
- VIGL
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for VIGL.
公司概览
业务概览
Vigil Neuroscience is a neuroscience company focused on microglia biology and neurodegenerative disease. Its programs aim at immune pathways in the brain rather than traditional symptomatic therapies.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Vigil sits in specialty neuroscience biotechnology.
商业模式特征
The business depends on translational data, target validation, and the potential to create a differentiated CNS franchise.
生物医药行业定位
Vigil is a platform CNS name whose valuation hinges on early clinical and mechanistic validation.
未来催化剂
- Vigil’s catalyst is VG-3927 and the rest of its microglia-focused neuroinflammation platform. The market will care about whether the biology can still produce a credible neurodegeneration story.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。